Investigational therapies targeted to the treatment of benign prostatic hyperplasia.
about
Dutasteride plus tamsulosin fixed-dose combination first-line therapy versus tamsulosin monotherapy in the treatment of benign prostatic hyperplasia: a budget impact analysis in the Greek healthcare setting.Advances in the design and discovery of drugs for the treatment of prostatic hyperplasia.A synopsis of drugs currently in preclinical and early clinical development for the treatment of benign prostatic hyperplasia.Emerging drugs for the treatment of benign prostatic hyperplasia.
P2860
Investigational therapies targeted to the treatment of benign prostatic hyperplasia.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Investigational therapies targeted to the treatment of benign prostatic hyperplasia.
@en
type
label
Investigational therapies targeted to the treatment of benign prostatic hyperplasia.
@en
prefLabel
Investigational therapies targeted to the treatment of benign prostatic hyperplasia.
@en
P2860
P1476
Investigational therapies targeted to the treatment of benign prostatic hyperplasia.
@en
P2093
Jean J M C H de la Rosette
Stavros Gravas
P2860
P304
P356
10.1517/13543784.2013.761973
P407
P577
2013-01-15T00:00:00Z